Page last updated: 2024-08-23

daunorubicin and n-(4-glucuronyl-3-nitrobenzyloxycarbonyl)doxorubicin

daunorubicin has been researched along with n-(4-glucuronyl-3-nitrobenzyloxycarbonyl)doxorubicin in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Andrianomenjanahary, S; Bosslet, K; Czech, J; Dong, X; Florent, JC; Gaudel, G; Gerken, M; Gesson, JP; Jacquesy, JC; Koch, M; Michel, S; Mitaku, S; Mondon, M; Monneret, C; Renoux, B; Straub, R; Tillequin, F1

Other Studies

1 other study(ies) available for daunorubicin and n-(4-glucuronyl-3-nitrobenzyloxycarbonyl)doxorubicin

ArticleYear
Prodrugs of anthracyclines for use in antibody-directed enzyme prodrug therapy.
    Journal of medicinal chemistry, 1998, Sep-10, Volume: 41, Issue:19

    Topics: Animals; Antibiotics, Antineoplastic; Antibodies, Monoclonal; Carcinoembryonic Antigen; Cell Division; Daunorubicin; Doxorubicin; Drug Screening Assays, Antitumor; Drug Stability; Escherichia coli; Glucuronates; Glucuronidase; Humans; Hydrolysis; Immunoglobulin Fab Fragments; Kinetics; Leukemia L1210; Mice; Prodrugs; Rats; Recombinant Fusion Proteins; Structure-Activity Relationship; Tumor Cells, Cultured

1998